Sania Therapeutics to Present at the American Society of Gene & Cell Therapy Annual Meeting
*Sania Therapeutics to Present at the American Society of Gene & Cell Therapy Annual Meeting*
LONDON, UK & NEW YORK, USA – 11 April 2024, Sania Therapeutics (the “Company”), focused on developing targeted genetic medicines for prevalent disorders today announces that it will be presenting three posters at the American Society of Gene & Cell Therapy 2024 Annual Meeting, taking place from 7-11 May 2024 in Baltimore, MD. Further details are below.
*Title:* Generating human-evolved, cell-type-specific AAV capsids for targeted gene delivery
*Session Date/Time: *5/8/2024 12:00:00 PM
*Session Title: *Wednesday Posters: AAV Vectors - Capsid Engineering
*Location: *Exhibit Hall
*Abstract Number: *503
*Title:* Titratable control of neuronal activity using precision genetic neuromodulation
*Session Date/Time: *5/10/2024 12:00:00 PM
*Session Title: *Friday Posters: Neurologic Diseases
*Location: *Exhibit Hall
*Abstract Number: *1606
*Title:* A low dose, targeted, and controllable gene therapy for the treatment of spasticity
*Session Date/Time: *5/9/2024 12:00:00 PM
*Session Title: *Thursday Posters: Neurologic Diseases
*Location: *Exhibit Hall
*Abstract Number: *1140
Abstracts details will be shared in due course and the posters will be made available on Sania’s website following their presentation.
*About Sania Therapeutics *
Sania Therapeutics is a ground-breaking biotechnology company pioneering new approaches for targeted and controllable gene therapies to access prevalent disorders. Sania's approach harnesses neural circuits as a gateway to disease states. Their research and development is centred around a human-first approach to ultimately build more translatable, safer and cost-effective AAV gene therapies capable of treating millions of patients. Sania is based in London, UK. For more information visit www.saniarx.com.
*Sania Therapeutics *
Andrew Murray
+4407354836683
info@saniarx.com*ICR Consilium*
Mary-Jane Elliott
Lucy Featherstone
+44 (0)20 3709 5700
saniatherapeutics@consilium-comms.com